secwatch.observer — SEC 8-K summary
======================================

Issuer:     PANACEA LIFE SCIENCES HOLDINGS, INC. (PLSH)
CIK:        0001552189
Form:       8-K/A
Filed at:   2021-12-17T23:59:59+00:00
Accession:  0001493152-21-031864
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Panacea Life Sciences 2020 revenue $9.0M, net loss $5.2M; auditor raises going concern
--------------------------------------------------------------------------------

- Revenue $9.0M in 2020 vs $2.2M in 2019; net loss $5.2M vs $2.8M.
- Cash dropped to $84K from $8.5M year-end 2019; total assets $31.4M, liabilities $24.7M.
- Auditor raises going concern due to recurring losses; company needs additional capital.
- Related party note payable $15.1M at Dec 2020; $1M additional financing received Nov 2021.
- Marketable securities (XXII shares) valued at $2.85M; unrealized gain $1.43M in 2020.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1552189/000149315221031864/0001493152-21-031864-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1552189/000149315221031864/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-031864

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer